Global Coronary Artery Disease Market Size By Treatment (Medication, Surgery), By End-User (Hospitals, Specialty Clinics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Geographic Scope And Forecast

Coronary Artery Disease Market Size And Forecast

Coronary Artery Disease Market size was valued at USD 21.07 Billion in 2021 and is projected to reach USD 45.23 Billion by 2030, growing at a CAGR of 8.86% from 2023 to 2030.

The market is primarily driven by the rise in coronary artery disease prevalence around the world, rising funding for research and development of therapies for the condition, and an increase in comorbid conditions including atherosclerosis and hypertension. The Global Coronary Artery Disease Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Coronary Artery Disease Market Definition

The medical disease known as coronary artery disease (CAD), often referred to as coronary heart disease (CHD) or ischemic heart disease, can be brought on by the narrowing or obstruction of the coronary arteries, the blood vessels that supply the heart muscle with oxygen and nutrients. The accumulation of fatty deposits termed plaque within the artery walls is often what causes this constriction or obstruction.

Think of atherosclerosis as the main culprit behind Coronary Artery Disease (CAD). Basically, it's like a slow buildup of gunk – we're talking cholesterol, fat, calcium, and other stuff – that forms plaque inside your coronary arteries. Over time, this plaque narrows the arteries, making it harder for oxygen-rich blood to get to your heart muscle. When your heart doesn't get enough oxygen, that's called ischemia, and it can cause that nasty chest pain known as angina. What puts you at risk? Things like smoking, high blood pressure, high cholesterol, diabetes, obesity, not getting enough exercise, a family history of heart disease, and just plain getting older all play a role.

Global Coronary Artery Disease Market Overview

The main factors influencing the coronary artery disease therapeutics market are the rising incidence and prevalence rates of hypertension, high cholesterol, diabetes, and obesity around the world, as well as government campaigns to raise public awareness of the disease. For instance, the National Institute of Health (NIH) 2022 estimates that in 2021 and 2022, the NIH will finance coronary heart diseases with USD 380 million and USD 395 million, respectively. As a result, increasing financing for CAD research will result in the development of novel medicines and an expansion of the market.

We're expecting the market to grow, partly because big players are stepping up with new ideas. For example, in December 2021, Novartis and the NHS in England made a deal to tackle high LDL-C (that's the bad cholesterol) in folks with coronary artery disease. Basically, the National Health Service (NHS) and Novartis are now putting into action the recommendation from the National Institute for Health and Care Excellence (NICE) to use inclisiran as a treatment for adults with CAD. This move is expected to boost the market as inclisiran becomes more common for treating CAD in developed countries like the UK.

Global Coronary Artery Disease Market Segmentation Analysis

The Global Coronary Artery Disease Market is Segmented on the basis of Diagnosis, Treatment, End-User, Distribution Channel, and Geography.

Coronary Artery Disease Market, By Treatment

• Medication
• Surgery
• Additional Therapy
• Other

Based on Treatment, the market is bifurcated into Medication, Surgery, Additional Therapy, and Other. These medications are used to treat CAD, manage risk factors such as high blood pressure and cholesterol, and lower the likelihood of heart-related incidents. Due to their widespread use as first-line treatments, medications frequently account for an important percentage of the CAD therapy market.

Coronary Artery Disease Market, By End-User

• Hospitals
• Specialty Clinics
• Other

Based on End-User, the market is bifurcated into Hospitals, Specialty Clinics, and Others. The majority of the Coronary Artery Disease Market is dominated by hospitals. This is due to the fact that hospitals act as the primary source for acute care, including the provision of emergency care for CAD-related events such as heart attacks. For procedures like angioplasty and coronary artery bypass surgery, hospitals have the appropriate infrastructure, including cardiac catheterization labs and operating rooms. For CAD patients, they also offer inpatient care and supervision.

Coronary Artery Disease Market, By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Based on Distribution Channel, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others. The provision of pharmaceuticals and medical equipment for the treatment of CAD is often heavily reliant on hospital pharmacies. Particularly for the distribution of medications for acute care and post-surgery, this channel frequently commands a considerable market share. Many CAD patients have their initial diagnoses and treatment in hospitals, and the pharmacies there frequently distribute medicines.

Coronary Artery Disease Market, By Diagnosis

• Electrocardiogram
• Echocardiogram
• Stress Test
• Cardiac Catheterization,
• Heart CT Scan
• Others

Based on Diagnosis, the market is bifurcated into Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, and Others).

Coronary Artery Disease Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

When we look at where the Coronary Artery Disease (CAD) market is happening globally, we can break it down by geographyNorth America, Europe, Asia Pacific, and everywhere else. Right now, North America is the biggest player. You see, countries like the United States have always had a significant chunk of the market. That's because of a few things, like a unfortunately high number of people with CAD risk factors, a pretty advanced healthcare system, and thriving pharmaceutical and medical device industries. The United States, in particular, is really pushing the boundaries when it comes to CAD research, treatments, and new medical technologies.

Key Players

The “Global Coronary Artery Disease Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer Inc., AstraZeneca, Novartis, Bristol-Myers Squibb, Merck & Co., Inc., Sanofi, Johnson & Johnson, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Siemens Healthineers, GE Healthcare, Philips Healthcare, Edwards Lifesciences, Terumo Corporation, Cordis Corporation, Roche, Eli Lilly and Company, Daiichi Sankyo, Amgen.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

 Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Coronary Artery Disease Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Coronary Artery Disease Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dive deep into the market with both numbers and stories, breaking it down by different groups considering things like wealth and even lifestyle choices. You'll get the market value (in USD Billion!) for every slice of the market we identify. We'll also point out which region and market segment we think will grow the fastest and be the biggest. We look at each geographic area to see how much of the product/service is being used and what's impacting the market there. Expect a rundown of the competition, including where the big players rank and what new stuff they've launched, plus partnerships, expansions, and acquisitions from the last five years. We also include detailed profiles of key companies with overviews, unique insights, product comparisons, and SWOT analyses. We'll give you our take on where the market is now and where it's headed, including recent happenings and what's driving growth versus what's holding it back in both up-and-coming and established regions. Expect an in-depth look at the market from all angles using Porter's Five Forces, plus we'll give you a peek into the market's Value Chain. Finally, we'll cover the market's likely path, highlighting growth opportunities, and we'll back it all up with 6 months of analyst support after the sale.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.